These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37265374)

  • 1. Confronting the challenge of gender nonconforming donors: A blood center's three-year experience.
    Reynolds V; Van Buren NL; Gorlin JB
    Transfusion; 2023 Jul; 63(7):1284-1289. PubMed ID: 37265374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donors.
    Van Buren NL; Rajbhandary S; Reynolds V; Gorlin JB; Stramer SL; Notari EP; Conti G; Katz L; Stubbs JR; van Buskirk CM; Kuttner K; Smith DL; Ngamsuntikul SG; Pandey S; Ward DC; Ziman A; Hiskey M; Townsend M; Sachais BS
    Transfusion; 2023 Mar; 63(3):552-563. PubMed ID: 36550639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of temporary deferrals on future blood donation behavior across the donor life cycle.
    Clement M; Shehu E; Chandler T
    Transfusion; 2021 Jun; 61(6):1799-1808. PubMed ID: 33780022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
    Yang Y
    Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Source plasma deferral trends: A 3-year analysis of 255 centers in the United States.
    Schmidt AE; MacKercher J; Youngling B; Simon TL
    J Clin Apher; 2022 Feb; 37(1):31-39. PubMed ID: 34799876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in presentation rates, deferrals and return behaviour among Norwegian blood donors.
    Misje AH; Bosnes V; Heier HE
    Vox Sang; 2010 Apr; 98(3 Pt 1):e241-8. PubMed ID: 19807904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing gender inclusivity for Two-Spirit, trans, nonbinary and other gender-diverse blood and plasma donors.
    Haw J; Butler-Foster T; Murray B; Lapierre D; Bosse J; Edwards J; Gümüşpala Ş; Jenkins C; Devor A
    Vox Sang; 2024 May; 119(5):409-416. PubMed ID: 38373848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of temporary deferrals on donor return: A 26-year assessment in a setting without retention activities.
    M Ferreira C; Vieites Y; Goldszmidt R; B Andrade E
    Transfusion; 2022 Aug; 62(8):1583-1593. PubMed ID: 35855649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new German blood donor questionnaire.
    Sümnig A; Lembcke H; Weber H; Deitenbeck R; Greffin K; Bux J; Greinacher A
    Vox Sang; 2014 Jan; 106(1):55-60. PubMed ID: 24117764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pre-donation deferrals--a teaching hospital experience.
    Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donor deferrals for malaria on blood availability in the United States.
    Leiby DA; Nguyen ML; Notari EP
    Transfusion; 2008 Oct; 48(10):2222-8. PubMed ID: 18673351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stigmatizing deferrals disproportionally reduce donor return rates: Evidence from Brazil.
    Vieites Y; Ferreira CM; Goldszmidt R; Andrade EB
    Vox Sang; 2024 Jun; 119(6):606-611. PubMed ID: 38425028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran.
    Rafiee MH; Kafiabad SA; Maghsudlu M
    Transfus Apher Sci; 2021 Apr; 60(2):103049. PubMed ID: 33468406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.
    O'brien SF; Chiavetta JA; Goldman M; Fan W; Nair RC; Sher GD; Vamvakas EC
    Transfusion; 2006 Mar; 46(3):461-8. PubMed ID: 16533291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of changes to donor hemoglobin criteria on the rate of donor deferral.
    Perez GE; Gammon RR; Whitaker BI; Vassallo RR; Stubbs JR
    Transfusion; 2018 Nov; 58(11):2581-2588. PubMed ID: 30264396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completing the Donor History Questionnaire before the Donation Visit Can Improve Blood Safety.
    Neugebauer J; Hagen C; Brockmann C; Juhl D; Schuster SO; Steppat D; Görg S; Ziemann M
    Transfus Med Hemother; 2022 Sep; 49(5):306-314. PubMed ID: 37969867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of questionnaires in preventing transfusion-transmitted infections.
    de Kort W; van den Burg P; Geerligs H; Pasker-de Jong P; Marijt-van der Kreek T
    Transfusion; 2014 Mar; 54(3 Pt 2):879-88. PubMed ID: 23889559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation.
    Bräuninger S; Thorausch K; Luxembourg B; Schulz M; Chow KU; Seifried E; Bonig H
    Bone Marrow Transplant; 2014 Nov; 49(11):1419-25. PubMed ID: 25089595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The science…or not behind deferrals of blood donors with a history of cancer.
    Gammon RR; Hopkins C; Mathur G; Rossmann SN; Sayers M; Straus T
    Transfusion; 2023 Aug; 63(8):1538-1545. PubMed ID: 37465955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.